SCHEMBL6096857

SCHEMBL6096857

C=Cc1ccc(OC)c(Br)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 3/20 0.59
TRPA1 O75762 1/20 0.56
POLB P06746 2/20 0.51
CTSL P07711 3/20 0.48
RECQL P46063 1/20 0.48
ALDH1A1 P00352 3/20 0.47
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
LMNA P02545 2/20 0.44
APP P05067 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TUBB4A P04350 1/20 0.44
TUBB P07437 1/20 0.44
TUBA3C P0DPH7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158026 0.84 TRPA1 (0.61) TUBB1TRPA1ALDH1A1APPCYP1A2
SCHEMBL29778007 0.81 TRPA1 (0.68) TUBB1TRPA1ALDH1A1APPCYP1A2
SCHEMBL33786 0.81 TRPA1 (0.68) TUBB1TRPA1ALDH1A1APPCYP1A2
SCHEMBL23143191 0.80 MAPT (0.47) TUBB1TRPA1POLBCTSLRECQL
SCHEMBL16953654 0.80 TUBB1 (0.59) TUBB1POLBCTSLRECQLALDH1A1
SCHEMBL6096855 0.80 TUBB1 (0.59) TUBB1POLBCTSLRECQLALDH1A1
SCHEMBL24758056 0.80 TUBB1 (0.59) TUBB1POLBCTSLRECQLALDH1A1
SCHEMBL155784 0.80 ALDH1A1 (0.68) TUBB1POLBCTSLRECQLALDH1A1
SCHEMBL29723752 0.80 ALDH1A1 (0.68) TUBB1POLBCTSLRECQLALDH1A1
SCHEMBL16955747 0.79 TRPA1 (0.40) TUBB1TRPA1POLBCTSLRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053216-B2 Modulators of Rho C activity ICONIX PHARMACEUTICALS, INC. (US) 2006-05-30 US claimed
US-20030171387-A1 Modulators of Rho C activity ENTELOS HOLDING CORP. 2003-09-11 US claimed
WO-2003043961-A2 MODULATORS OF RHO C ACTIVITY ICONIX PHARMACEUTICALS, INC. (US) 2003-05-30 WO claimed
US-20250122152-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-04-17 US disclosed
WO-2025068943-A1 KAT6 INHIBITORS BEIGENE SWITZERLAND GMBH (CH) 2025-04-03 WO disclosed
EP-3782977-A1 CYCLOPROPANATION METHOD AND REAGENT Fundació Privada Institut Català d'Investigació Química (ICIQ) (ES) 2021-02-24 EP disclosed
EP-3782977-A1 CYCLOPROPANATION METHOD AND REAGENT Fundació Privada Institut Català d'Investigació Química (ICIQ) (ES) 2021-02-24 EP disclosed
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
WO-2008103125-A1 NOVEL COMBINATION OF COMPOUNDS TO BE USED IN THE TREATMENT OF AIRWAY DISEASES, ESPECIALLY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND ASTHMA ASTRAZENECA AB (SE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030171387-A1 Modulators of Rho C activity RHOC, ROCK1, CIT TUBB1 1345/4885TRPA1 4154/4885POLB 3377/4885
US-20250122152-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT7 TUBB1 185/4885TRPA1 3212/4885POLB 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.